Sinopep receives FDA on-site inspection

In late April 2016, the company was audited by US FDA for an on-site API inspection which lasted for 5 days. The production area, material warehouses, quality system, etc were strictly inspected by the auditor. During the audit, staff from each department detailedly answered the questions raised by the auditor and helped the auditor fully understand the production status and quality safety of the company’s products. After the audit, the auditor convened a closing meeting, concluded the inspection and praised the company, and raised several problems as well. This inspection means a qualitative improvement for Sinopep, and also an affirmation for the company’s quality system. We will take this opportunity to step forward.

  • Peptides
  • Generic APIs
  • Custom Peptide Synthesis